In focus · trending topic

Antibiotics in development

22 stories · following the connections

Melinta Therapeutics Launches Antibiotic Baxdela™ (delafloxacin) in the United States

By Nasdaq OMXJan 29, 2018, 12:00 PM UTC

Melinta Therapeutics Announces Initiation of Program for Radezolid in Patients with Bacterial Vaginosis

By Nasdaq OMXJan 18, 2018, 12:00 PM UTC

Melinta Therapeutics to Present at 36th Annual J.P. Morgan Healthcare Conference

By Nasdaq OMXJan 3, 2018, 12:00 PM UTC

Melinta Therapeutics Appoints Lisa DeFrancesco as Senior Vice President of Investor Relations

By Nasdaq OMXJan 2, 2018, 12:00 PM UTC

Melinta Therapeutics Enters Into Agreement to Acquire Infectious Disease Business from The Medicines Company

By Nasdaq OMXNov 29, 2017, 12:00 PM UTC

Melinta Therapeutics Announces Successful Completion of Merger

By Nasdaq OMXNov 6, 2017, 1:01 PM UTC

Melinta Therapeutics’ Topical Radezolid Well Tolerated in Phase 1 Study for Treatment of Acne

By Nasdaq OMXOct 10, 2017, 12:00 PM UTC

Melinta Therapeutics Presents Outcomes of Baxdela Treatment of Gram-Positive and Gram-Negative Pathogens at IDWeek

By Nasdaq OMXOct 4, 2017, 5:14 PM UTC